[1] |
Leventhal J,Abecassis M,Miller J, et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med, 2012, 4(124): 124ra28.
|
[2] |
Chaidos A,Patterson S,Szydlo R, et al. Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. Blood, 2012, 119(21): 5030-5036.
|
[3] |
Ahmed A,Keeffe EB. Current indications and contraindications for liver transplantation. Clin Liver Dis, 2007, 11(2): 227-247.
|
[4] |
沈中阳,陈新国.临床肝移植. 2版.北京:科学出版社, 2010: 2-4.
|
[5] |
Volk ML,Hernandez JC,Lok AS, et al. Modified Charlson comorbidity index for predicting survival after liver transplantation. Liver Transpl, 2007, 13(11): 1515-1520.
|
[6] |
Zimmerman JE,Kramer AA,McNair DS, et al. Acute physiology and chronic health evaluation (APACHE) Ⅳ: hospital mortality assessment for today's critically ill patients. Crit Care Med, 2006, 34(5): 1297-1310.
|
[7] |
Zimmerman JE,Kramer AA,McNair DS, et al. Intensive care unit length of stay: benchmarking based on acute physiology and chronic health evaluation (APACHE) Ⅳ. Crit Care Med, 2006, 34(10): 2517-2529.
|
[8] |
赵耐青.临床医学研究设计和数据分析.上海:复旦大学出版社,2005: 241-252.
|
[9] |
Knaus WA,Zimmerman JE,Wagner DP, et al. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med, 1981, 9(8): 591-597.
|
[10] |
Knaus WA,Draper EA,Wagner DP, et al. APACHE Ⅱ: a severity of disease classification system. Crit Care Med, 1985, 13(10): 818-829.
|
[11] |
Knaus WA,Wagner DP,Draper EA, et al. The APACHE Ⅲ prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest, 1991, 100(6): 1619-1636.
|
[12] |
Doyle HR,Marino IR. Effect of donor age liver allograft function. Transplantation, 1996, 61(7): 1129-1131.
|
[13] |
Yersiz H,Shaked A,Olthoff K, et al. Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation, 1995, 60(8): 790-794.
|
[14] |
Brinkman S,Bakhshi-Raiez F,Abu-Hanna A, et al. External validation of acute physiology and chronic health evaluation Ⅳ in Dutch intensive care units and comparison with acute physiology and chronic health evaluation Ⅱ and simplified acute physiology score Ⅱ. J Crit Care, 2011, 26(1): 105.
|
[15] |
Nassar AP Jr,Mocelin AO,Nunes AL, et al. Caution when using prognostic models: a prospective comparison of 3 recent prognostic models. J Crit Care, 2012, 27(4): 423.
|
[16] |
Knaus WA. APACHE 1978-2001: the development of a quality assurance system based on prognosis: milestones and personal reflections. Arch Surg, 2002, 137(1): 37-41.
|
[17] |
Zimmerman JE,Alzola C,Von Rueden KT. The use of benchmarking to identify top performing critical care units: a preliminary assessment of their policies and practices. J Crit Care, 2003, 18(2): 76-86.
|
[18] |
Berenholtz SM,Dorman T,Ngo K, et al. Qualitative review of intensive care unit quality indicators. J Crit Care, 2002, 17(1): 1-12.
|
[19] |
Kramer AA,Zimmerman JE. A predictive model for the early identification of patients at risk for a prolonged intensive care unit length of stay. BMC Med Inform Decis Mak, 2010, 10: 27.
|
[20] |
Vasilevskis EE,Kuzniewicz MW,Cason BA, et al. Mortality probability model Ⅲ and simplified acute physiology score Ⅱ: assessing their value in predicting length of stay and comparison to APACHE Ⅳ. Chest, 2009, 136(1): 89-101.
|